Literature DB >> 17143565

WNT antagonist, DKK2, is a Notch signaling target in intestinal stem cells: augmentation of a negative regulation system for canonical WNT signaling pathway by the Notch-DKK2 signaling loop in primates.

Masuko Katoh1, Masaru Katoh.   

Abstract

Notch and WNT signaling pathways are key components of the stem cell signaling network. Canonical WNT signaling to intestinal progenitor cells leads to transcriptional activation of the JAG1 gene, encoding Serrate-type Notch ligand. JAG1 then binds to the Notch receptor on adjacent stem cells to induce Notch receptor proteolyses for the release of Notch intracellular domain (NICD). NICD is associated with CSL/RBPSUH and Mastermind (MAML1, MAML2, or MAML3) to activate Notch target genes, such as HES1 and HES5. Although WNT-dependent Notch signaling activation in intestinal stem cells is clarified, the effects of Notch signaling activation on WNT signaling in progenitor cells remain unclear. We searched for Notch-response element (NRE) in the promoter region of genes encoding secreted WNT signaling inhibitors, including DKK1, DKK2, DKK3, DKK4, SFRP1, SFRP2, SFRP3, SFRP4, SFRP5 and WIF1. Double NREs were identified within human DKK2 promoter by bioinformatics and human intelligence (Humint). The human DKK2 gene was characterized as Notch signaling target in intestinal stem cells. Because DKK2 is a key player in the stem cell signaling network, the DKK2 gene at human chromosome 4q25 is a candidate tumor suppressor gene inactivated due to epigenetic silencing and/or deletion. The chimpanzee DKK2 gene was identified within the NW_105990.1 genome sequence, while the cow Dkk2 gene was identified within the AC156664.2 and AC158038.2 genome sequences. Chimpanzee DKK2 and cow Dkk2 showed 98.5% and 95.8% total-amino-acid identity with human DKK2, respectively. Double NREs in human DKK2 promoter were conserved in chimpanzee DKK2 promoter, partially in rat Dkk2 promoter, but not in cow and mouse Dkk2 promoters. The Notch-DKK2 signaling loop, created or potentiated in primates, was complementary to WNT-DKK1 and BMP-IHH-SFRP1 signaling loops for negative regulation of canonical WNT signaling pathway. Together, these facts indicate that DKK2 promoter evolution resulted in the augmentation of a WNT negative regulation system in primates.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17143565

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  9 in total

1.  DNAJB6 governs a novel regulatory loop determining Wnt/β-catenin signalling activity.

Authors:  Mitchell E Menezes; Aparna Mitra; Lalita A Shevde; Rajeev S Samant
Journal:  Biochem J       Date:  2012-06-15       Impact factor: 3.857

2.  The WNT antagonist Dickkopf2 promotes angiogenesis in rodent and human endothelial cells.

Authors:  Jeong-Ki Min; Hongryeol Park; Hyun-Jung Choi; Yonghak Kim; Bo-Jeong Pyun; Vijayendra Agrawal; Byeong-Wook Song; Jongwook Jeon; Yong-Sun Maeng; Seung-Sik Rho; Sungbo Shim; Jin-Ho Chai; Bon-Kyoung Koo; Hyo Jeong Hong; Chae-Ok Yun; Chulhee Choi; Young-Myoung Kim; Ki-Chul Hwang; Young-Guen Kwon
Journal:  J Clin Invest       Date:  2011-04-11       Impact factor: 14.808

3.  Regeneration of Sensory Hair Cells Requires Localized Interactions between the Notch and Wnt Pathways.

Authors:  Andrés Romero-Carvajal; Joaquín Navajas Acedo; Linjia Jiang; Agnė Kozlovskaja-Gumbrienė; Richard Alexander; Hua Li; Tatjana Piotrowski
Journal:  Dev Cell       Date:  2015-07-16       Impact factor: 12.270

4.  Beta-catenin/TCF4 transactivates miR-30e during intestinal cell differentiation.

Authors:  Y Liao; B Lönnerdal
Journal:  Cell Mol Life Sci       Date:  2010-04-08       Impact factor: 9.261

5.  Lung tumor cells inhibit bone mineralization and osteoblast activity.

Authors:  Taylor E Berent; Jessica M Dorschner; Theodore A Craig; Matthew T Drake; Jennifer J Westendorf; Rajiv Kumar
Journal:  Biochem Biophys Res Commun       Date:  2019-09-16       Impact factor: 3.575

6.  DKK2 blockage-mediated immunotherapy enhances anti-angiogenic therapy of Kras mutated colorectal cancer.

Authors:  Jiajia Hu; Zhengting Wang; Zhengxi Chen; Ao Li; Jing Sun; Minhua Zheng; Jibo Wu; Tianli Shen; Ju Qiao; Lin Li; Biao Li; Dianqing Wu; Qian Xiao
Journal:  Biomed Pharmacother       Date:  2020-05-20       Impact factor: 6.529

7.  Notch signaling in cardiovascular disease and calcification.

Authors:  Gabriel Rusanescu; Ralph Weissleder; Elena Aikawa
Journal:  Curr Cardiol Rev       Date:  2008-08

8.  Expression profiling of in vivo ductal carcinoma in situ progression models identified B cell lymphoma-9 as a molecular driver of breast cancer invasion.

Authors:  Hanan S Elsarraj; Yan Hong; Kelli E Valdez; Whitney Michaels; Marcus Hook; William P Smith; Jeremy Chien; Jason I Herschkowitz; Melissa A Troester; Moriah Beck; Marc Inciardi; Jason Gatewood; Lisa May; Therese Cusick; Marilee McGinness; Lawrence Ricci; Fang Fan; Ossama Tawfik; Jeffrey R Marks; Jennifer R Knapp; Hung-Wen Yeh; Patricia Thomas; D R Carrasco; Timothy A Fields; Andrew K Godwin; Fariba Behbod
Journal:  Breast Cancer Res       Date:  2015-09-17       Impact factor: 6.466

9.  DKK2 Impairs Tumor Immunity Infiltration and Correlates with Poor Prognosis in Pancreatic Ductal Adenocarcinoma.

Authors:  Jianyu Yang; Yongsheng Jiang; Ruizhe He; Wei Liu; Minwei Yang; Lingye Tao; Xueliang Fu; Yang Shen; Jiao Li; Dejun Liu; Yanmiao Huo; Junfeng Zhang; Rong Hua; Zhigang Zhang; Yongwei Sun
Journal:  J Immunol Res       Date:  2019-09-08       Impact factor: 4.818

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.